Cargando…
Data Management in a Regulatory Context
With the implementation of Article 57(2) in 2012 the European Medicines Agency (EMA) embarked on a digitalization journey that foreseeably would ensure greater product oversight and interoperability across the community. This initiative has subsequently led to additional focus from the agency with r...
Autor principal: | Grønning, Niels |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519530/ https://www.ncbi.nlm.nih.gov/pubmed/28785556 http://dx.doi.org/10.3389/fmed.2017.00114 |
Ejemplares similares
-
Regulatory Approval With Real-World Data From Regulatory Science Perspective in Japan
por: Maeda, Hideki, et al.
Publicado: (2022) -
Differences in affect integration in children with and without internalizing difficulties
por: Fiskum, Charlotte, et al.
Publicado: (2021) -
When does doctor’s recommendation become patient’s resolution? The regulatory potential of procedural justice in the context of compliance with medical advice and the treatment process
por: Prusiński, Tomasz
Publicado: (2023) -
Transferability of real-world data across borders for regulatory and health technology assessment decision-making
por: Jaksa, Ashley, et al.
Publicado: (2022) -
Medicines management support to older people: understanding the context of systems failure
por: Rogers, Stephen, et al.
Publicado: (2014)